argenx SE (ARGX) income statement
NASDAQ · Healthcare · Biotechnology · 1,863 employees · CEO Karen Massey
- Price
- $892.87 -0.55%
- Market cap
- $56.1B
- Enterprise value
- $53.2B
- Last report
- Q4 '26 filed 2026-09-30
- Next report
- 2027-02-25 EPS est. $7.70
argenx SE (ARGX) reported revenue of $1.72B for Q4 '26 (+200.2% year on year), operating income of $485M (28.2% of revenue) and net income of $506M. Over the last four quarters revenue was –.
Income statement
| Income statement | Trend | Q2 '21 | Q4 '21 | Q2 '22 | Q4 '22 | Q2 '23 | Q4 '23 | Q2 '24 | Q4 '24 | Q2 '25 | Q4 '25 | Q2 '26 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $499M | $26.8M | $111M | $313M | $511M | $330M | $401M | $573M | $948M | $3.21B | $2.82B | $1.72B | |
| Cost of revenue | $274M | $307M | $272M | $381M | -$456M | $36M | $43.2M | $59.1M | $111M | $340M | $279M | $165M | |
| Gross profit | $225M | -$277M | $459M | -$77.7M | $924M | $294M | $358M | $514M | $837M | $2.87B | $2.54B | $1.56B | |
| Research & development | $272M | $304M | $276M | $384M | $358M | $192M | $225M | $236M | $328M | $443M | $486M | $503M | |
| Sales & marketing | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $240M | $0 | |
| General & administrative | $0 | $0 | $0 | $0 | $311M | $0 | $0 | $0 | $0 | $0 | $533M | $0 | |
| Other operating expenses | -$270M | -$314M | -$284M | -$388M | -$357M | -$9.31M | -$9.72M | -$13.7M | -$15.7M | $1.22B | $431M | -$30M | |
| Operating expenses | $130M | $167M | $218M | $224M | $313M | $374M | $451M | $500M | $633M | $2.01B | $1.69B | $1.07B | |
| Operating income | $95.1M | -$457M | -$397M | -$341M | -$206M | -$80.6M | -$93.4M | $14.2M | $204M | $851M | $847M | $485M | |
| Interest income | $0 | $3.36M | $5.71M | $22M | $37.1M | $30M | $38.9M | $40.6M | $38.4M | $44M | $92.1M | $45M | |
| Interest expense | $744K | $0 | $2.12M | $1.78M | $396K | $231K | $512K | $676K | $1.13M | $1M | $2M | $1M | |
| Other non-operating income (gains on investments, FX ...) | $40.1M | $9.8M | $3.44M | $3.34M | -$1.72M | $2.46M | -$19.6M | -$74.5M | -$84.2M | -$144M | $0 | -$54M | |
| Total non-operating income | -$19.1M | -$17.9M | -$49.8M | $38.5M | $45.8M | -$2.69M | $19.1M | $73.8M | $83.1M | $141M | $112M | $53M | |
| Income before tax | $76M | -$474M | -$447M | -$303M | -$160M | -$83.3M | -$74.4M | $88M | $287M | $992M | $959M | $538M | |
| Income tax | $10.8M | -$4.31M | -$11.1M | $8.61M | $36.8M | -$10.6M | -$12.8M | -$3.39M | $41.5M | -$55M | $119M | $32M | |
| Net income | $53.3M | -$414M | -$416M | -$256M | -$113M | -$72.6M | -$61.6M | $91.4M | $245M | $1.05B | $839M | $506M | |
| EPS (basic) | $1.25 | -$8.04 | -$7.78 | -$4.62 | -$2.03 | -$1.25 | -$1.04 | $1.52 | $6.85 | $14.25 | $13.49 | $8.07 | |
| EPS (diluted) | $0.99 | -$8.04 | -$7.78 | -$4.62 | -$2.03 | -$1.25 | -$1.04 | $1.39 | $6.37 | $13.22 | $13.02 | $7.80 | |
| Shares (basic, weighted) | 54M | 51.5M | 53.5M | 55.3M | 55.7M | 58.1M | 59.3M | 60.1M | 61M | 61.4M | 62.2M | 62.7M | |
| Shares (diluted, weighted) | 54M | 51.5M | 53.5M | 55.3M | 55.7M | 58.1M | 59.3M | 65.8M | 65.7M | 66.2M | 64.4M | 64.9M | |
| Depreciation & amortization | $2.96M | $2.9M | $3.05M | $101M | $2.69M | $103M | $8.61M | $8.89M | $13.4M | $14.8M | $17M | $0 | |
| EBITDA | $98.1M | -$397M | -$419M | -$204M | -$184M | $20.4M | -$65.2M | $97.6M | $301M | $1.01B | $864M | $539M |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15.5M | $43.7M | $24.6M | $78.5M | $41.2M | $1.08B | $411M | $1.23B | $2.19B | $4.15B | |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $581M | $29.4M | $118M | $227M | $451M | |
| Gross profit | $15.5M | $43.7M | $24.6M | $78.5M | $41.2M | $497M | $381M | $1.11B | $1.96B | $3.7B | |
| Research & development | $33.2M | $62.1M | $95.6M | $221M | $370M | $581M | $663M | $859M | $983M | $1.36B | |
| Sales & marketing | $0 | $0 | $0 | $0 | $0 | $60M | $116M | $202M | $307M | $429M | |
| General & administrative | $7.37M | $14.9M | $25.6M | $72.1M | $171M | $246M | $354M | $507M | $748M | $931M | |
| Other operating expenses | -$2.57M | -$5.81M | -$3.77M | -$15.6M | -$22.2M | -$40M | -$31.6M | -$35.5M | -$54.2M | -$75.9M | |
| Operating expenses | $38M | $71.2M | $118M | $277M | $519M | $846M | $1.1B | $1.53B | $1.98B | $2.65B | |
| Operating income | -$22.5M | -$27.5M | -$93.6M | -$199M | -$478M | -$349M | -$720M | -$425M | -$21.7M | $1.05B | |
| Interest income | $64.2K | $198K | $4.23M | $8.81M | $5.15M | $3.49M | $24.7M | $93M | $138M | $163M | |
| Interest expense | $0 | $0 | $0 | $139K | $404K | $1.1M | $2.19M | $904K | $2.22M | $4.08M | |
| Other non-operating income (gains on investments, FX ...) | $0 | $5.46M | $0 | -$23.1M | $127M | $49.9M | $6.78M | -$121M | -$109M | -$228M | |
| Total non-operating income | $44.2K | -$5.46M | $18.3M | $23M | -$128M | -$51M | -$8.97M | $121M | $107M | $224M | |
| Income before tax | -$22.5M | -$33M | -$75.3M | -$176M | -$605M | -$400M | -$729M | -$304M | $85.2M | $1.28B | |
| Income tax | $0 | $716K | $908K | $5.29M | $3.1M | $8.52M | -$19.7M | -$9.44M | -$748M | -$13.4M | |
| Net income | -$22.5M | -$33.7M | -$76.2M | -$181M | -$608M | -$408M | -$710M | -$295M | $833M | $1.29B | |
| EPS (basic) | -$1.19 | -$1.37 | -$2.12 | -$4.69 | -$13.40 | -$7.99 | -$13.05 | -$5.16 | $13.92 | $21.14 | |
| EPS (diluted) | -$1.20 | -$1.37 | -$2.12 | -$4.69 | -$13.40 | -$7.99 | -$13.05 | -$5.16 | $12.78 | $19.63 | |
| Shares (basic, weighted) | 18.8M | 24.6M | 36M | 38.6M | 45.4M | 51.1M | 54.4M | 57.2M | 59.9M | 61.3M | |
| Shares (diluted, weighted) | 18.8M | 24.6M | 36M | 38.6M | 45.4M | 51.1M | 54.4M | 57.2M | 65.2M | 66M | |
| Depreciation & amortization | $351K | $522K | $564K | $2.43M | $3.92M | $5.87M | $104M | $111M | $17.5M | $28.1M | |
| EBITDA | -$22.2M | -$32.4M | -$93.1M | -$173M | -$601M | -$393M | -$623M | -$192M | $105M | $1.31B |
Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics and estimates: Financial Modeling Prep.
Data as of 2026-11-02